Santa Cruz Biotechnology delivers a wide array of ZNF133 monoclonal antibodies for research focused on understanding ZNF133 protein function. The monoclonal antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). ZNF133, a member of the zinc finger protein family, plays a crucial role in gene regulation and cellular processes. ZNF133 is involved in transcriptional activation and has been linked to various biological functions, including cell differentiation and proliferation. Understanding ZNF133 function is essential for elucidating its implications in developmental biology and disease mechanisms. Researchers can utilize multiple detection methods, including horseradish peroxidase (HRP), phycoerythrin (PE), and fluorescein isothiocyanate (FITC) conjugates for enhanced visualization and analysis. Current research continues to reveal new insights about ZNF133's role in cellular pathways and potential therapeutic applications. Santa Cruz Biotechnology monoclonal antibodies enable researchers worldwide to advance scientific understanding of ZNF133 and its impact on human health and disease.